173 related articles for article (PubMed ID: 19481112)
1. Development and optimization of a high-throughput electrophysiology assay for neuronal alpha4beta2 nicotinic receptors.
Sidach SS; Fedorov NB; Lippiello PM; Bencherif M
J Neurosci Methods; 2009 Aug; 182(1):17-24. PubMed ID: 19481112
[TBL] [Abstract][Full Text] [Related]
2. In vitro screening strategies for nicotinic receptor ligands.
Dunlop J; Roncarati R; Jow B; Bothmann H; Lock T; Kowal D; Bowlby M; Terstappen GC
Biochem Pharmacol; 2007 Oct; 74(8):1172-81. PubMed ID: 17706607
[TBL] [Abstract][Full Text] [Related]
3. Agonist-induced hump current production in heterologously-expressed human alpha4beta2-nicotinic acetylcholine receptors.
Liu Q; Yu KW; Chang YC; Lukas RJ; Wu J
Acta Pharmacol Sin; 2008 Mar; 29(3):305-19. PubMed ID: 18298895
[TBL] [Abstract][Full Text] [Related]
4. Regulation of human alpha4beta2 neuronal nicotinic acetylcholine receptors by cholinergic channel ligands and second messenger pathways.
Gopalakrishnan M; Molinari EJ; Sullivan JP
Mol Pharmacol; 1997 Sep; 52(3):524-34. PubMed ID: 9281615
[TBL] [Abstract][Full Text] [Related]
5. 5-I A-85380 and TC-2559 differentially activate heterologously expressed alpha4beta2 nicotinic receptors.
Zwart R; Broad LM; Xi Q; Lee M; Moroni M; Bermudez I; Sher E
Eur J Pharmacol; 2006 Jun; 539(1-2):10-7. PubMed ID: 16674940
[TBL] [Abstract][Full Text] [Related]
6. Untranslated region-dependent exclusive expression of high-sensitivity subforms of alpha4beta2 and alpha3beta2 nicotinic acetylcholine receptors.
Briggs CA; Gubbins EJ; Marks MJ; Putman CB; Thimmapaya R; Meyer MD; Surowy CS
Mol Pharmacol; 2006 Jul; 70(1):227-40. PubMed ID: 16569710
[TBL] [Abstract][Full Text] [Related]
7. Differential inhibition of nicotine- and acetylcholine-evoked currents through alpha4beta2 neuronal nicotinic receptors by tobacco cembranoids in Xenopus oocytes.
Eaton MJ; Ospina CA; Rodríguez AD; Eterović VA
Neurosci Lett; 2004 Aug; 366(1):97-102. PubMed ID: 15265598
[TBL] [Abstract][Full Text] [Related]
8. alpha4beta2 nicotinic receptors with high and low acetylcholine sensitivity: pharmacology, stoichiometry, and sensitivity to long-term exposure to nicotine.
Moroni M; Zwart R; Sher E; Cassels BK; Bermudez I
Mol Pharmacol; 2006 Aug; 70(2):755-68. PubMed ID: 16720757
[TBL] [Abstract][Full Text] [Related]
9. Potentiation of human alpha4beta2 neuronal nicotinic receptors by a Flustra foliacea metabolite.
Sala F; Mulet J; Reddy KP; Bernal JA; Wikman P; Valor LM; Peters L; König GM; Criado M; Sala S
Neurosci Lett; 2005 Jan; 373(2):144-9. PubMed ID: 15567570
[TBL] [Abstract][Full Text] [Related]
10. Sazetidine-A, a novel ligand that desensitizes alpha4beta2 nicotinic acetylcholine receptors without activating them.
Xiao Y; Fan H; Musachio JL; Wei ZL; Chellappan SK; Kozikowski AP; Kellar KJ
Mol Pharmacol; 2006 Oct; 70(4):1454-60. PubMed ID: 16857741
[TBL] [Abstract][Full Text] [Related]
11. Gene regulation of alpha4beta2 nicotinic receptors: microarray analysis of nicotine-induced receptor up-regulation and anti-inflammatory effects.
Hosur V; Leppanen S; Abutaha A; Loring RH
J Neurochem; 2009 Nov; 111(3):848-58. PubMed ID: 19732285
[TBL] [Abstract][Full Text] [Related]
12. Cholinergic drugs potentiate human nicotinic alpha4beta2 acetylcholine receptors by a competitive mechanism.
Smulders CJ; Zwart R; Bermudez I; van Kleef RG; Groot-Kormelink PJ; Vijverberg HP
Eur J Pharmacol; 2005 Feb; 509(2-3):97-108. PubMed ID: 15733544
[TBL] [Abstract][Full Text] [Related]
13. Validation of a high-throughput, automated electrophysiology platform for the screening of nicotinic agonists and antagonists.
Graef JD; Benson LC; Sidach SS; Wei H; Lippiello PM; Bencherif M; Fedorov NB
J Biomol Screen; 2013 Jan; 18(1):116-27. PubMed ID: 22960782
[TBL] [Abstract][Full Text] [Related]
14. Nicotine-induced increase in neuronal nicotinic receptors results from a decrease in the rate of receptor turnover.
Peng X; Gerzanich V; Anand R; Whiting PJ; Lindstrom J
Mol Pharmacol; 1994 Sep; 46(3):523-30. PubMed ID: 7935334
[TBL] [Abstract][Full Text] [Related]
15. Novel acetylcholine and carbamoylcholine analogues: development of a functionally selective alpha4beta2 nicotinic acetylcholine receptor agonist.
Hansen CP; Jensen AA; Christensen JK; Balle T; Liljefors T; Frølund B
J Med Chem; 2008 Dec; 51(23):7380-95. PubMed ID: 18989912
[TBL] [Abstract][Full Text] [Related]
16. [Electrophysiological characteristics of the open state of neuronal alpha4beta2, alpha4beta4 and alpha7-nicotinic acetylcholine receptors].
Luo WQ; Cui WY; Wang H
Zhongguo Ying Yong Sheng Li Xue Za Zhi; 2009 Aug; 25(3):392-6. PubMed ID: 21155245
[TBL] [Abstract][Full Text] [Related]
17. High-throughput screening for Kv1.3 channel blockers using an improved FLIPR-based membrane-potential assay.
Liu K; Samuel M; Tillett J; Hennan JK; Mekonnen B; Soloveva V; Harrison RK; Paslay JW; Larocque J
J Biomol Screen; 2010 Feb; 15(2):185-95. PubMed ID: 20044579
[TBL] [Abstract][Full Text] [Related]
18. Dual action of n-butanol on neuronal nicotinic alpha4beta2 acetylcholine receptors.
Zuo Y; Yeh JZ; Narahashi T
J Pharmacol Exp Ther; 2003 Mar; 304(3):1143-52. PubMed ID: 12604691
[TBL] [Abstract][Full Text] [Related]
19. Tobacco particulate matter is more potent than nicotine at upregulating nicotinic receptors on SH-SY5Y cells.
Ambrose V; Miller JH; Dickson SJ; Hampton S; Truman P; Lea RA; Fowles J
Nicotine Tob Res; 2007 Aug; 9(8):793-9. PubMed ID: 17654292
[TBL] [Abstract][Full Text] [Related]
20. U18666A, a cholesterol-inhibition agent, modulates human neuronal nicotinic acetylcholine receptors heterologously expressed in SH-EP1 cell line.
Zheng C; Wang MY; Liu Q; Wakui M; Whiteaker P; Lukas RJ; Wu J
J Neurochem; 2009 Mar; 108(6):1526-38. PubMed ID: 19183258
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
